Eligible patients can receive up to 70 per cent in subsidies for genetic tests, while MediShield Life coverage will be extended to selected risk-reducing surgical procedures.
Malay Mail on MSN
Singapore to subsidise genetic testing for high-risk breast, ovarian cancer patients
SINGAPORE, March 5 — From December, Singaporeans identified as high risk for hereditary breast and ovarian ...
Doctors warn that Bulgaria’s healthcare system still lacks a sustainable framework for genomic diagnostics, patients are paying the price ...
A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.
Colorectal cancer is highly preventable, and early detection saves lives. Colon Cancer Awareness Month is an ideal time for ...
Spain has begun using a new genetic ALS therapy that targets the SOD1 mutation and may slow nerve damage in patients with this rare condition.
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
Private companies are capitalizing on this quest for information. Grail’s Galleri blood test screens for more than 50 ...
Advances in organ and computer models are raising the prospect that some animal experiments could be eliminated. But there ...
A 56-year-old man with liver failure has become the first living person to be surgically connected to a genetically modified ...
Doctors address the pros and cons of Health Resources and Services Administration’s new guidance, including at-home ...
A South Yorkshire woman is facing a terrifying wait for a life-saving mastectomy, despite being at high genetic risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results